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pFGE is the paralog of the formylglycine-generating
enzyme (FGE), which catalyzes the oxidation of a specific
cysteine to C-formylglycine, the catalytic residue in the
active site of sulfatases. The enzymatic activity of sulfat-
ases depends on this posttranslational modification, and
the genetic defect of FGE causes multiple sulfatase defi-
ciency. The structural and functional properties of pFGE
were analyzed. The comparison with FGE demonstrates
that both share a tissue-specific expression pattern and
the localization in the lumen of the endoplasmic reticu-
lum. Both are retained in the endoplasmic reticulum by a
saturable mechanism. Limited proteolytic cleavage at
similar sites indicates that both also share a similar three-
dimensional structure. pFGE, however, is lacking the
formylglycine-generating activity of FGE. Although over-
expression of FGE stimulates the generation of catalyti-
cally active sulfatases, overexpression of pFGE has an
inhibitory effect. In vitro pFGE interacts with sulfatase-
derived peptides but not with FGE. The inhibitory effect
of pFGE on the generation of active sulfatases may there-
fore be caused by a competition of pFGE and FGE for
newly synthesized sulfatase polypeptides.
The catalytic site of pro- and eukaryotic sulfatases contains
a unique amino acid, C-formylglycine (FGly)1 (1–9). The FGly
participates as an aldehyde hydrate in the catalytic cleavage of
sulfate esters and thus is essential for the activity of sulfatases
(10–12). The FGly residue is posttranslationally generated
from a specific cysteine (pro- and eukaryotes) or serine (pro-
karyotes) residue. In humans, the FGly-generating enzyme
(FGE) is encoded by the SUMF1 gene (13, 14). Mutations in the
SUMF1 gene are the cause of multiple sulfatase deficiency, a
rare autosomal recessive disorder, in which all sulfatases are
synthesized as catalytically inactive polypeptides lacking FGly
in their catalytic sites (1, 2, 13–15). The SUMF1 gene is highly
conserved among pro- and eukaryotes (16).
In the genomes of deuterostomia, including vertebrates and
echinodermata, a paralog of the SUMF1 gene, designated as
SUMF2, is found (13–15).2 Gene duplication of a common
SUMF ancestor gene obviously has occurred at the level of a
single exon gene after the evolution of insects and before that of
deuterostomia. The function of the SUMF2-encoded paralog of
FGE (pFGE) is unknown. Cotransfection of SUMF2 with sul-
fatase cDNAs such as those of arylsulfatase A, C, or E en-
hanced moderately, but consistently, the catalytic activity of
the sulfatases, suggesting that pFGE has some FGly-generat-
ing activity (13). So far, no mutations in the SUMF2 gene have
been found in multiple sulfatase deficiency patients. In the
present study, we have analyzed the expression of SUMF2 and
the structural and functional properties of recombinant and
endogenous pFGE and examined the interaction with and mod-
ifying activity of pFGE on sulfatases.
EXPERIMENTAL PROCEDURES
Cloning of Human pFGE Encoding cDNA (SUMF2)—Total RNA,
prepared from human fibroblasts using the RNeasy Mini kit (Qiagen),
was reverse-transcribed using the Omniscript reverse transcriptase kit
(Qiagen), and either an oligo(dT) primer or the SUMF2-specific primer
1072nc (5-GGAAGGGGAAGTTCTTTCC-3). The first strand cDNA
was amplified by PCR using the forward primer 1c (5-ATGCG-
CAGCGGGGCCGTGG-3) and, as reverse primer, either 1072nc or
1049nc (5-GCTGAAGCTCTCGAGCTTGG-3). The PCR products were
cloned directly into the pCR4-TOPO vector (Invitrogen). By sequencing
multiples of the cloned PCR products, which had been obtained from
various individuals and from independent reverse transcriptase and
PCR reactions, the cDNA sequence coding for pFGE (906 bp from start
to stop codon) was established. The sequence corresponds to Gen-
BankTM entry NM_015411 but deviates in one position (87CT). This
change is a silent mutation in the third position of the serine 29 codon
and may reflect a polymorphism.
Construction of Expression Plasmids—The pFGE encoding cDNA
was equipped with a 5 BamHI site and a 3 RGS-His6 tag sequence
followed by a stop codon and a XbaI site, by add-on PCR using PfuUltra
polymerase (Stratagene) and primers 5-CGGGATCCACCATGGCCCG-
GCATGGGTTAC-3 (BamHI) and 5-GCTCTAGATTAGTGATGGT-
GATGGTGATGCGATCCTCTCAGCTCCCCTGGCGGC-3 (RGS-His6-
XbaI). The resulting PCR product was cloned as a BamHI/XbaI
fragment downstream of the cytomegalovirus promotor of the expres-
sion vector pSB4.7pA, which was provided by Transkaryotic Therapies
Inc. (Cambridge, MA).
For coexpression of FGE or pFGE with steroid sulfatase, the pBI
vector (BD Biosciences) was used, which allows expression of two
cDNAs from a bidirectional tet-responsive promotor. The FGE- (14) and
* This work was supported by the Deutsche Forschungsgemeinschaft,
the Fonds der Chemischen Industrie and Transkaryotic Therapies, Inc.
(Cambridge, MA). The costs of publication of this article were defrayed
in part by the payment of page charges. This article must therefore be
hereby marked “advertisement” in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§ Present address: Biochemie I, Universita¨t Bielefeld, Universita¨t-
strasse 25, 33615 Bielefeld, Germany.
¶ To whom correspondence is addressed. Tel.: 49-551-395948; Fax:
49-551-395979; E-mail: kfigura@gwdg.de.
1 The abbreviations used are: FGly, C-formylglycine; ASA, arylsulfatase
A; Bpa, p-benzoyl phenylalanine; FGE, FGly-generating enzyme; pFGE,
paralog of FGE; MALDI-TOF, matrix-assisted laser desorption/ionization
time-of-flight; Ni-NTA, nickel-nitrilotriacetic acid; HA, hemagglutinin;
PNGase, peptide-N-glycosidase. 2 T. Pringle, personal communication.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 280, No. 15, Issue of April 15, pp. 15173–15179, 2005
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 15173
 at M
ax Planck Inst.Biophysikalische Chem
ie,O
tto Hahn Bibl,Pf.2841,37018 G
oettingen on M









pFGE-encoding cDNAs were equipped with a 5 EcoRV site and a 3HA
tag sequence followed by a stop codon and a NotI site, by add-on PCR







The EcoRV/NotI-digested PCR products were inserted into the mul-
tiple cloning site II of the pBI vector that had been opened by PstI,
blunted with T4-polymerase/dNTPs, and cut with NotI. It should be
noted that after ligation, the initial EcoRV and PstI sites were de-
stroyed. Into the multiple cloning site I of the obtained constructs and
of the empty pBI vector, the steroid sulfatase cDNA was cloned as an
NheI/EcoRV fragment. This fragment was generated from a PCR prod-
uct that was obtained using pBEH-STS (17) as template, Pfu Ultra
polymerase, and add-on primers 5-CTAGCTAGCCACCATGCCTTTA-
AGGAAGATGAAG-3 (NheI) and 5-GGATATCAGCGGCTCAGTCTC-
TTATCC-3 (EcoRV).
Northern Blot Analysis—A human multitissue Northern blot (BD
Biosciences) was hybridized with 32P-labeled cDNA probes covering the
entire coding regions of FGE or pFGE, respectively, and a -actin cDNA
probe as a control for RNA loading. Basically the same result, as shown
below (see Fig. 1), was obtained when using probes hybridizing in the
3-untranslated regions of SUMF1 or SUMF2 mRNA, in which the two
sequences show no similarity (not shown). It was verified before each
hybridization round that no radioactivity had remained from the pre-
vious hybridization. For technical details, see Ref. 18.
Cell Culture and Transfections—HT-1080 cells and human skin fi-
broblasts were grown in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum and 1% penicillin/streptomycin (In-
vitrogen) under 5% CO2 at 37 °C. Transient transfection was performed
with Lipofectamine 2000 following the protocol recommended by In-
vitrogen. Typically, 4 g of plasmid DNA were used per 6-cm dish. For
coexpression experiments, the cells were transfected with a mix of 2 g
of pBI vector containing pFGE- (or FGE-) and steroid sulfatase-encod-
ing cDNAs plus 2 g of rtTA plasmid (reverse tetracycline controlled
transactivator, BD Biosciences). For triple expression experiments, the
cells were transfected with a mixture of three plasmids: 1 g of pBI
vector containing only pFGE cDNA, 1 g of pBI vector containing FGE,
and steroid sulfatase cDNAs and 2 g of rtTA vector. After 6 h, the
medium was replaced with medium containing 1 g/ml doxycyline
(BD Biosciences), and 30 h later, the cells were harvested for further
analysis. For stable transfection, HT-1080 cells were transfected with
pSB-pFGE-His (see above). Clones were selected and screened accord-
ing to Ref. 19. HT-1080 cells stably expressing galactose 6-sulfatase
were kindly provided by Transkaryotic Therapies Inc. (Cambridge,
MA) and cotransfected with pSB-pFGE-His plus the puromycin re-
sistance vector pSV-pac (20) (1:10 ratio). Transfectants were selected
in normal growth medium containing puromycin (Invitrogen) with an
increasing concentration from 0.2 to 0.8 g/ml and screened by West-
ern blotting.
Purification of Recombinant pFGE-His—HT-1080 cells stably over-
expressing pFGE-His were grown to near confluence in normal growth
medium. Then medium was collected every 48 h, cleared by spinning,
and subjected to ammonium sulfate precipitation as described (19). The
precipitate was reconstituted in and dialyzed against lysis buffer (50
mM NaH2PO4, 300 mM NaCl, and 10 mM imidazole, pH 8.0). The
dialyzed material was cleared (142,000  g, Ti45 rotor, 30 min, 4 °C)
and subjected to Ni-NTA affinity chromatography under the conditions
recommended by the manufacturer (Qiagen). Peak fractions, analyzed
by Western blotting, were pooled and dialyzed overnight against Buffer
A (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 2.5 mM dithiothreitol). The
dialyzed pFGE-His was applied to a MonoQ HR10/10 anion exchange
column (Amersham Biosciences) equilibrated with Buffer A. The pFGE-
His protein was recovered in the flow-through and concentrated in an
Ultra Thimble UH 100/25 (Schleicher & Schuell).
Indirect Immunofluorescence and Immunoelectron Microscopy—To
detect endogenous expression of pFGE, human skin fibroblasts were
grown on coverslips for 2 days. For recombinant expression of pFGE,
the HT-1080 cells were grown on coverslips and cotransfected with
pBI-pFGE-HA and rtTA plasmids, as described above. After 36 h of
transfection, the cells were analyzed by indirect immunofluorescence as
described (19). For colocalization studies, rabbit pFGE-His antiserum
or monoclonal antibodies against the HA tag (Covance Inc., Princeton,
NJ) were used as primary antibodies. The endoplasmic reticulum
marker protein, protein disulfide isomerase, was detected with a mono-
clonal antibody of IgG2A subtype (StressGen Biotechnologies). The pri-
mary antibodies were detected with isotype-specific goat secondary
antibodies coupled to Cy2 or Cy3 (Molecular Probes), respectively. Con-
focal images were taken on a Leica TCS SP2 AOBS laser scan
microscope.
For immunoelectron microscopy, ultrathin cryosections were pre-
pared as described (19). For immunolabeling, sections were incubated
with a polyclonal antibody against pFGE (1:25) for 30 min followed by
a 20-min incubation with protein A-gold (10 nm). After washing steps,
sections were fixed for 5 min with 1% glutaraldehyde. Sections were
then quenched with glycine and blocked with bovine serum albumin
before they were incubated with monoclonal antibodies against pro-
tein disulfide isomerase (1:30, StressGen Biotechnologies) or LAMP I
(1:25, Hybridoma Bank) followed by a bridge antibody for 30 min
(rabbit anti-mouse) and protein A-gold (5 nm) for 20 min. Sections
were contrasted with uranyl acetate/methyl-cellulose for 10 min on
ice, embedded in the same solution, and examined with a Philips
CM120 electron microscope.
Endoglucosaminidase H/PNGase Treatment and Immunoprecipita-
tion—HT-1080 cells stably expressing pFGE-His were grown to conflu-
ence. After 48 h in fresh medium, cells and medium were collected for
partial purification of pFGE-His by Ni-NTA chromatography and en-
doglucosaminidase H or PNGase treatment as described (19).
Limited Proteolysis and Protein Sequence Analysis—pFGE-His puri-
fied from the secretion of HT-1080 cells was treated with thermolysin or
elastase in phosphate-buffered saline at a protein/protease ratio of 25:1
(w/w) for up to 24 h at ambient temperature. For further analysis of the
digests by SDS-PAGE and N-terminal sequencing of the proteolytic
fragments, see Ref. 19.
Reductive Carbamidomethylation and Tryptic Digestion, MALDI-
TOF Mass Spectrometry, and Edman Sequencing—Reductive carb-
amidomethylation and tryptic digestion of purified pFGE-His were
done, as described (19). To keep disulfide bridges intact, reduction
with dithiothreitol has been omitted in one experiment. Also MALDI-
TOF mass spectrometry and Edman sequencing have been described
(19).
Metabolic Labeling and Immunoprecipitation—Normal human skin
fibroblasts were grown to near confluence in 3-cm dishes, starved in 2
ml of methionine and cysteine-free Dulbecco’s modified Eagle’s medium
for 1 h, and pulsed for 6 h with 2 ml of medium containing 50 Ci of
35S-labeled methionine and cysteine supplemented with 10% dialyzed
fetal calf serum. Cells were harvested either directly or after washing
with cold phosphate-buffered saline and culturing in 2 ml of chase
medium (Dulbecco’s modified Eagle’s medium containing 10% fetal
calf serum) for another 16 h (chase). Medium was collected, and cells
were harvested by scraping. Immunoprecipitation of pFGE from cells
and medium was performed with a pFGE anti-serum according to a
protocol described earlier (21). Pellets were finally solubilized and
subjected to SDS-PAGE and phosphorimaging (BAS1000, Raytest).
Densitometric quantification of pFGE was done using the MacBAS
software (Fuji).
Activity Assays for Sulfatases and FGE—Activity assays of FGE,
steroid sulfatase, and galactose 6-sulfatase were performed as de-
scribed earlier (14, 22, 23). For Western blot analysis, steroid sulfatase
antiserum, galactose 6-sulfatase monoclonal antibodies (provided by
Transkaryotic Therapies Inc., Cambridge, MA), and HA tag monoclonal
antibodies (see above) were used as primary antibodies, which were
detected with secondary horseradish peroxidase-conjugated goat anti-
rabbit or anti-mouse antibodies. The Western blot signals were quan-
tified by using the AIDA 2.1 software package (Raytest).
Photocross-linking—For photoaffinity labeling, a benzophenone-la-
beled peptide was synthesized corresponding to arylsulfatase A (resi-
dues 60–80) with an additional -biotinylated lysine residue at the N
terminus, an additional serine amide at the C terminus, and a p-
benzoyl phenylalanine replacing leucine 77. The reaction mixture, con-
taining 50 M benzophenone-labeled peptide, 1 M pFGE-His, bovine
serum albumin, or FGE-His was photocross-linked and analyzed by
Western blotting as described (19).
Yeast Two-hybrid Analysis—The human pFGE cDNA (encoding res-
idues 26–301) was inserted into the pGBKT7 bait vector (BD Bio-
sciences) in-frame with the GAL4 DNA binding domain-encoding se-
quence. The human FGE cDNA (encoding amino acids 87–374) or ASA
cDNA (encoding residues 19–114) was cloned into the pGADT7 prey
vector (BD Biosciences) containing the GAL4 DNA-activating domain.
Cotransformation of yeast cells (AH109), selection of cotransformants,
and analysis for expression of HIS3, ADE2, and MEL1 reporters was
performed, as described (19).
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Expression of SUMF2—A single SUMF2 transcript of 2.0–
2.1 kb is detectable by Northern blot analysis of poly(A) RNA
from heart, brain, placenta, lung, liver, skeletal muscle, kid-
ney, and pancreas (Fig. 1A) and of total RNA from skin fibro-
blasts (not shown). The expression pattern compares well with
that of SUMF1 (Fig. 1B), the relative ratio of SUMF2 over
SUMF1 varying between 0.5 in heart and 1.4 in brain and
pancreas. Relative to -actin RNA (not shown), the abundance
of SUMF2 RNA varies by one order of magnitude, being high-
est in pancreas and kidney and lowest in brain.
Characterization of Recombinant pFGE—pFGE with a C-
terminal HA tag was transiently expressed in the human HT-
1080 sarcoma cell line. pFGE colocalized with protein disulfide
isomerase, a lumenal protein of the endoplasmic reticulum
(Fig. 2, A–C). In some cells, such as those shown in Fig. 2, A–C,
a fraction of pFGE was associated with perinuclear structures
devoid of protein disulfide isomerase. This structure is en-
riched in the Golgi marker protein GM130 (not shown). This
indicates that recombinant pFGE is localized in the endoplas-
mic reticulum, but in some cells, can also accumulate in detect-
able amounts in the Golgi apparatus. Immunoelectronmicros-
copy confirmed the localization of pFGE in the endoplasmic
reticulum, where it colocalizes with protein disulfide isomerase
(Fig. 3A) and in the Golgi stack (Fig. 3B). A sparse labeling for
pFGE was observed in structures enriched in the endosomal/
lysosomal marker LAMP I (Fig. 3B).
Overexpressed pFGE-His is only transiently retained in the
endoplasmic reticulum. In HT-1080 cells, most of the pFGE-His
that was synthesized over a period of 2 days (93% of total) was
secreted. During that period, the cellular pFGE was kept at a
rather constant level (Fig. 4).
pFGE contains a single potentialN-glycosylation site at Asn-
191. The intracellular 32-kDa pFGE-His was sensitive to en-
doglucosaminidase H and PNGaseF. Both endoglycosidases de-
creased the apparent molecular size of the intracellular pFGE
by 2.5 kDa (Fig. 5), indicating that intracellular pFGE contains
a high mannose (or hybrid) type oligosaccharide. The secreted
pFGE is represented by a 31.5- and 32.5-kDa form. Both are
converted into a 29.5-kDa polypeptide by PNGaseF, indicating
that the two forms arise from heterogeneous N-glycosylation.
The 31.5-kDa form is sensitive to endoglucosaminidase H,
whereas the 32.5-kDa form is resistant (Fig. 5). This indicates
that the 31.5-kDa form contains a high mannose type oligosac-
charide, whereas the 32.5-kDa form contains a complex type
oligosaccharide. MALDI-TOF analysis of the N-glycosylated
tryptic peptide 179–192 of secreted pFGE-His confirmed its
heterogeneous glycosylation at Asn-191. The oligosaccharide
mixture was composed of 11 different species. They all be-
longed to the hybrid or complex type with up to five N-acetyl-
hexosamine, six hexose, one sialic acid, and one fucose residue/
FIG. 1. Expression of pFGE (A) and FGE (B) in human tissues.
Northern blot analysis of poly(A) RNA from human tissues. For -ac-
tin abundance of the same blot, see Fig. 4 in Ref. 14. Very similar
expression patterns were obtained when using probes hybridizing ei-
ther in the coding region, as shown here, or in the non-conserved
3-untranslated region (not shown).
FIG. 2. Subcellular localization of pFGE-HA in HT-1080 cells
and endogenous pFGE in human skin fibroblasts. After fixation
and permeabilization of pFGE-HA overexpressing HT-1080 cells (A–C)
or human skin fibroblasts (D–F), protein disulfide isomerase (PDI) was
detected with a monoclonal IgG2A antibody (green, A and D), the HA tag
of pFGE (red, B) with a monoclonal IgG1 antibody, and pFGE (red, E)
with a rabbit antiserum. The merge reveals colocalization of protein
disulfide isomerase and pFGE in yellow (C and F).
FIG. 3. Localization of pFGE-His in HT-1080 cells by immuno-
electron microscopy. After fixation and cryosectioning, pFGE was
detected with a rabbit antiserum against pFGE and protein A-gold (10
nm). A shows double labeling with the endoplasmic reticulum marker
protein disulfide isomerase (5 nm gold), and B shows double labeling
with the endosome/lysosome marker LAMP I (5 nm gold). ER, GApp,
and MVB designate endoplasmic reticulum, Golgi apparatus, and mul-
tivesicular bodies, respectively. The scale bar corresponds to 100 nm.
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oligosaccharide and masses ranging from 1768 to 2424 Da (not
shown).
pFGE-His purified from the secretions of HT-1080 cells was
incubated with elastase or thermolysin at a pFGE/protease
ratio of 25:1. Both proteases generated two families of frag-
ments of about 10–12 and 22–24 kDa (Fig. 6). The fragments
generated by thermolysin were subjected to N-terminal amino
acid sequencing. The 10–12-kDa fragments represent the
amino terminus of mature pFGE starting with residue 27,
whereas the 22–24-kDa fragments start with threonine 109 or
with valine 115. Phylogenetic sequence conservation analysis
has revealed three subdomains in pFGE (Fig. 6, bottom) (Ref.
16). The proteolytic cleavage sites are located in the linker
region between subdomain I and II, which extends from serine
93 to leucine 116.
To examine for a possible disulfide bonding of the two
cysteine residues in pFGE (at positions 156 and 290), pFGE-
His purified from the secretions was first reacted with N-
ethylmaleimide, to modify free cysteine residues, and then
subjected to reductive carbamidomethylation in the presence
of urea to modify disulfide-bonded cysteines. After digestion
with trypsin, the peptides were separated by reversed phase
high performance liquid chromatography on a C18 matrix
and characterized by MALDI-TOF mass spectrometry and
N-terminal amino acid sequencing. The two cysteine-contain-
ing tryptic peptides (154–159 and 290–303) were exclusively
recovered as carbamidomethylated derivatives, indicating
that cysteine 156 and cysteine 290 are disulfide-bonded in
pFGE. In fact, when pFGE was subjected to carbamido-
methylation in the presence of urea without prior reduction
and then digested with trypsin, the two tryptic peptides
154–159 and 290–303 were found to be connected by a disul-
fide bond. Since non-reduced pFGE migrates in SDS-PAGE
as a monomer (not shown), cysteine 156 and 290 form an
intramolecular rather than an intermolecular disulfide bond.
Localization and Secretion of Endogenous pFGE—Antisera
against pFGE-His, purified from the secretions of HT-1080
cells, were generated in rabbits. These antisera were suitable
for indirect immunofluorescence, immunoprecipitation, and
Western blots.
When fibroblasts, fixed with paraformaldehyde and perme-
abilized with saponin, were reacted with anti-pFGE serum,
pFGE was detectable in the endoplasmic reticulum, where it
colocalized with protein disulfide isomerase (Fig. 2, D–F). As-
sociation with the Golgi, as observed for overexpressed pFGE
(Fig. 2, B and C), was not detectable for endogenous pFGE.
To follow biosynthesis and secretion of endogenous pFGE,
human skin fibroblasts were metabolically labeled for 6 h with
[35S]methionine. After labeling, the cells were either harvested
or subjected to a 16-h chase in [35S]methionine-free medium.
pFGE was immunoprecipitated from extracts of the cells and
from media, separated by SDS-PAGE, and visualized by phos-
phorimaging (Fig. 7). pFGE was synthesized as a 32-kDa
polypeptide that remained stable during the 16-h chase period.
After the chase for 16 h, a small amount (less than 13%) was
recovered in the secretions as 31.5- and 32.5-kDa forms. This
indicates that differently from recombinant pFGE, only a small
fraction of endogenous pFGE escapes retention in the endoplas-
mic reticulum. Heterogeneous processing of the N-linked oligo-
saccharide in the secretory pathway is likely to give rise to the
two 31.5- and 32.5-kDa pFGE forms in the secretions, as has
been shown for recombinant pFGE (cf. Fig. 5).
pFGE Lacks FGly-generating Activity—pFGE is the paralog
of FGE, which has FGly-generating activity. The generation of
the FGly residue is readily detectable with the help of the
23-mer peptide P23 derived from arylsulfatase A (14). This
peptide contains the cysteine residue to be modified and neigh-
boring residues, which are essential for FGly formation. The
FGly-generating activity in extracts of HT-1080 cells tran-
siently expressing pFGE-His (Fig. 8) or non-tagged pFGE (not
shown) was in the range of non-transfected HT-1080 cells,
whereas FGly-generating activity in extracts of cells express-
ing a comparable amount of FGE-His was more than 20-fold
increased (Fig. 8). When purified pFGE-His was incubated
with the P23 peptide under conditions that allow quantitative
modification of the cysteine residue by purified FGE-His, no
FGly formation was detectable. Increasing or decreasing the
FIG. 4. Secretion of pFGE-His by HT-1080 cells. HT-1080 cells
stably expressing pFGE-His were grown to half-confluency. At time 0,
fresh medium was added, and the cells were harvested after 12, 24, 36,
and 48 h of culture. pFGE was quantified in equal aliquots of cell
extracts (C) and media (M) by Western blotting using a monoclonal
antibody against the His6 tag (inset). The amount of intracellular and
secreted pFGE-His per mg of cell protein was determined by calibration
of the Western blot with known amounts of purified pFGE-His and
referred to total cell protein.
FIG. 5. N-Glycosylation of intracellular and secreted pFGE-
His. Cell extracts and secretions of HT-1080 cells expressing pFGE-His
were treated with endoglucosaminidase H (EndoH) or PNGaseF, sepa-
rated by SDS-PAGE, and analyzed by Western blotting using anti-His
antibodies. The filled arrowheads point to the glycosylated pFGE form,
and the open arrowheads to the deglycosylated pFGE form.
FIG. 6. Limited proteolysis of pFGE-His by thermolysin and
elastase. pFGE-His purified from secretions of HT-1080 cells was
incubated for up to 24 h with thermolysin or elastase, as indicated, at a
pFGE/protease ratio of 25:1 (w/w). After separation by SDS-PAGE, the
polypeptides were detected by staining with Coomassie Blue. The mo-
lecular masses of pFGE and the proteolytic fragments are indicated at
the right. The scheme at the bottom shows the locations of the predicted
subdomains I, II, and III together with the residue numbers defining
the N and C termini of mature pFGE and its subdomains. The arrows
indicate the two proteolytic cleavage sites of thermolysin N-terminal of
threonine 109 and valine 115, as determined by Edman sequencing.
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amount of pFGE-His did not result in any FGly formation. In
addition, we examined peptides, derived from the other 15
human sulfatases, as substrates for pFGE. Although all pep-
tides were modified in vitro by FGE (19), none of them were
modified by pFGE. This indicates that pFGE lacks FGly-gen-
erating activity.
Overexpression of pFGE Impairs Sulfatase Activity—In vivo,
the activity of FGE can be a limiting factor for the synthesis of
catalytically active sulfatases. This becomes apparent when
sulfatases are overexpressed. The yield of sulfatase activity is
increased by simultaneous overexpression of FGE (13, 14).
When FGE was transiently coexpressed with steroid sulfat-
ase in HT-1080 cells, the activity of steroid sulfatase increased
about 2-fold. In contrast, coexpression of pFGE reduced the
sulfatase activity by about half (Fig. 9). The inhibitory effect
may indicate that pFGE competes with the endogenous FGE
for modification of the recombinant steroid sulfatase. In line
with this assumption, we observed that coexpression of pFGE
and FGE abolished the stimulatory effect of FGE on steroid
sulfatase activity (Fig. 9). Control experiments verified that
both tagged and non-tagged pFGE fail to activate steroid sul-
fatase (not shown).
A similar result was observed when pFGE-His and galactose
6-sulfatase were stably coexpressed in HT-1080 cells. Coex-
pression of pFGE-His reduced the specific activity of the galac-
tose 6-sulfatase by 20% (not shown), whereas coexpression of
FGE increased the specific activity of galactose-6-sulfatase
more than 100-fold.3 The different efficiencies of FGE-mediated
activation and pFGE-mediated inhibition in the two experi-
ments are explained by the much higher expression of galac-
tose 6-sulfatase, as compared with that of steroid sulfatase.
This by far exceeded the FGly-generating capacity of endoge-
nous FGE, thus leaving large amounts of unmodified galactose
6-sulfatase as a substrate for the recombinant FGE. Accord-
ingly, the lower inhibitory effect of coexpressed pFGE on ga-
lactose 6-sulfatase may be due to the high expression level of
this sulfatase, clearly exceeding that of pFGE. Taken together,
these data support the view that pFGE has no FGly-generating
activity toward the three sulfatases tested (arylsulfatase A,
steroid sulfatase, and galactose-6-sulfatase). The inhibitory ef-
fect of pFGE in vivo on the formation of active sulfatases
suggests that pFGE can interfere with the activity of FGE on
sulfatases. A number of mechanisms are conceivable to explain
the inhibitory effect of pFGE on the generation of catalytically
active sulfatases. Among them are binding of pFGE to FGE
or/and to sulfatases and thereby interfering with the modifica-
tion of nascent sulfatase polypeptides by FGE.
Binding of pFGE to Sulfatases—Binding of FGE to sulfata-
ses has been demonstrated in several experimental systems.
When extracts of HT-1080 cells coexpressing FGE-His and
galactose 6-sulfatase are subjected to gel permeation chroma-
tography, complexes of FGE and galactose 6-sulfatase coelute.3
In cells coexpressing pFGE-His and galactose 6-sulfatase, we
failed to observe complexes. pFGE-His and galactose-6-sulfat-
ase eluted as monomers of 20 and 55 kDa, respectively (not
shown).
A peptide representing arylsulfatase A residues 60–80, but
carrying a p-benzoyl phenylalanine (Bpa) at position 77 and a
biotinylated lysine residue at the N terminus, can be pho-
tocross-linked to FGE (Fig. 10, lane 5). Replacing FGE by
pFGE, we also observed cross-linking of the peptide to pFGE,
albeit at only one-tenth of the efficiency observed for FGE-His
(Fig. 10, lane 1). Cross-linking was specific as indicated by the
inhibitory effect of a 2-fold excess of the arylsulfatase A 60–80
peptide P23 (Fig. 10, lane 2) and by the lack of cross-link3 M. Mariappan, unpublished information.
FIG. 7. Biosynthesis and secretion of endogenous pFGE. pFGE
was immunoprecipitated from the cells and media of human skin fibro-
blast that had been labeled for 6 h and harvested either directly after
metabolic labeling or after a chase period of 16 h. The arrows indicate
the intracellular 32-kDa pFGE form (left) and the secreted 31.5- and
32.5-kDa forms (right).
FIG. 8. FGE activity in HT-1080 cells expressing pFGE-His or
FGE-His. The upper panel shows the Western blot detection of pFGE-
His and FGE-His in the cell extracts with a monoclonal antibody
against the His6 tag. The lower panel shows the FGly-generating activ-
ity in the cell extracts determined in vitro with the P23 peptide as
substrate. Bar 1, non-transfected HT-1080 cells; bars 2 and 3, cells
transiently expressing pFGE-His or FGE-His, respectively.
FIG. 9. pFGE-HA reduces and FGE-HA enhances the activity of
steroid sulfatase. In HT-1080 cells, steroid sulfatase (STS), pFGE-
HA, and FGE-HA were transiently coexpressed in the combinations
indicated below the lanes. In the cell extracts, the expression of steroid
sulfatase, pFGE-HA, and FGE-HA was monitored by Western blotting
using a rabbit antiserum against steroid sulfatase and a monoclonal
antibody against the HA tag (top). The activity of steroid sulfatase,
referred to total cell protein, is shown at the bottom. It should be noted
that the transfected cDNAs were located on two vectors, one vector
coexpressing steroid sulfatase and, where indicated, FGE-HA from a
bidirectional promotor, and another vector expressing pFGE-HA only
(see “Experimental Procedures”).
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products when bovine serum albumin (Fig. 10, lane 4), ovalbu-
min, or ribonuclease were used as acceptor proteins. When
biotinylated ASA peptides with Bpa residues in position 62 or
66 were used, the cross-linking efficiency was further lowered
and substitution of the critical cysteine 69 by alanine reduced
cross-linking to pFGE 10-fold (not shown).
An interaction of pFGE with arylsulfatase A was observed in
a yeast two-hybrid system. Using pFGE as bait and an aryl-
sulfatase A fragment comprising residues 19–114 as prey, a
two-hybrid interaction was observed for three reporter genes
(HIS3, ADE2, and MEL1) expressed under the control of three
distinct GAL4 responsive elements (Fig. 11).
Interaction of pFGE and FGE—The interaction between
pFGE and FGE was also examined with the help of a yeast
two-hybrid system. Coexpression of pFGE (residues 26–301)
and FGE (residues 87–374) induced the expression of three
reporter genes (HIS3, ADE2, and MEL1) (Fig. 12). Reporter
gene expression was independent of whether FGE or pFGE was
expressed as bait or prey hybrid proteins.
All attempts failed to verify a direct interaction of pFGE and
FGE by demonstration of co-purification during gel permeation
chromatography, Ni-NTA-agarose pull-down or chemical cross-
linking of the two proteins employing extracts of pFGE-His and
FGE coexpressing cell lines (data not shown). We also exam-
ined whether the addition of pFGE to a mixture of FGE and its
peptidic substrate P23 would inhibit the FGly formation. pFGE
added in an up to 300-fold molar excess over FGE had no effect
on FGly formation, neither at a low P23 concentration close to
its Km (13 nM) nor at a saturating P23 concentration (200 nM).
Thus, in vitro pFGE has no inhibitory effect on FGE activity
toward peptidic substrates.
DISCUSSION
The present study demonstrates that pFGE and FGE share
many structural and topological properties but differ function-
ally. FGE catalyzes in sulfatases the oxidation of a cysteine
residue to the active site FGly residue, whereas pFGE lacks
such an activity both in vitro and in vivo.
The nucleotide sequence of pFGE predicts an N-terminal
signal peptide directing translocation of the nascent polypep-
tide into the lumen of the endoplasmic reticulum. pFGE was
indeed found to be a soluble glycoprotein of the endoplasmic
reticulum. Although only a small fraction of endogenous
pFGE escapes from the endoplasmic reticulum into secre-
tions, overexpression of pFGE results in its massive secre-
tion. pFGE is therefore likely to be retained in the endoplas-
mic reticulum by a saturable mechanism. It should be noted
that pFGE lacks an endoplasmic reticulum retention signal
of the KDEL type, suggesting that it is retained by binding to
some other resident component of the endoplasmic reticulum.
During secretion, the single high mannose type oligosaccha-
ride of pFGE becomes processed to hybrid and complex type
structures containing fucose and sialic acid residues. Since
for intracellular pFGE only the high mannose type oligosac-
charide was found, the residence in the Golgi, as detected in
some overexpressing cells (Fig. 2C), is negligible, and expo-
sure to Golgi-dependent modification reactions is restricted
to the fraction of pFGE that escapes endoplasmic reticulum
retention and becomes secreted.
Phylogenetic sequence conservation analysis has revealed
that pFGE and FGE contain three highly conserved regions. In
pFGE, these subdomains make up more than 85% of the mol-
ecule. Digestion with elastase, a serine proteinase, or thermo-
lysin, a zinc-metalloproteinase, generated two stable frag-
ments by cleavage within the short linker sequence connecting
the first and the second subdomain. This may indicate that the
three conserved regions are part of two folding domains.
FGE contains three fully conserved cysteine residues in the
highly conserved C-terminal subdomain III. Two of them have
been suspected to be critical for catalytic activity (19). They
both are lacking in pFGE. pFGE contains only two cysteine
residues, one located in subdomain II (Cys-156) and another
one located in subdomain III (Cys-290). They form an intramo-
lecular disulfide bond linking subdomains II and III. This di-
sulfide bond is conserved in FGE, in which two intersubdomain
disulfide bridges link subdomains II and III (19). Therefore, in
FIG. 10. Photocross-linking of pFGE-His to an arylsulfatase A
peptide. pFGE-His (lanes 1–3), bovine serum albumin (BSA, lane 4) or
FGE-His (lane 5), 1 M each, were incubated with 50 M biotin-P23-
Bpa77, a peptide corresponding to arylsulfatase A residues 60–80 with
an additional -biotinylated lysine residue at the N terminus, a C-
terminal serine amide residue and a Bpa replacing leucine 77. In lane
2, a 2-fold excess of peptide P23, corresponding to arylsulfatase A
residues 60–80 with an additional N-acetylated methionine and a
C-terminal serine amide residue, was added. After irradiation with UV
light for 30 min on ice, equal aliquots of the samples were subjected to
SDS-PAGE, transferred onto a nitrocellulose membrane, and probed
with antibodies against the His tag (upper panel) or biotin (lower panel).
The positions of bovine serum albumin, FGE, and pFGE are indicated
by arrows.
FIG. 11. Yeast two-hybrid interaction of pFGE and arylsulfat-
ase A. Yeast cells were cotransformed with a prey vector containing an
ASA insert (codons 19–114) and a bait vector containing a pFGE insert
(codons 26–301); , vector without insert. Cotransformants were se-
lected on medium lacking tryptophan and leucine. Two-hybrid interac-
tion leads to reporter activation allowing growth on selection medium
that lacks, as indicated, histidine, adenine, or both, in addition to
tryptophan and leucine.
FIG. 12. Yeast two-hybrid interaction of pFGE and FGE. The
inserts of the bait (pFGE codons 26–301) and the prey (FGE codons
87–374) vector used for cotransformation of yeast cells are indicated (,
vector without insert). For further detail, see the legend for Fig. 11.
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pFGE as well as in FGE, subdomains II and III are tightly
connected and together form a large protease-resistant domain.
The localization, carbohydrate processing, and secretion
upon overexpression as well as the protease sensitivity of the
linker region between the first two subdomains are properties
that pFGE shares with its paralog FGE (19). Moreover, the
relative abundance of their RNAs in different tissues is rather
similar. All these observations suggest that pFGE and FGE
fulfil similar functions. A known and important functional
property of FGE is its FGly-generating activity, an essential
protein modification for sulfatases that renders them catalyti-
cally active. The critical role of FGE for the FGly formation is
evident from the loss of catalytically active, FGly-containing
sulfatases in patients that carry mutations in the SUMF1 gene
encoding FGE (13–15). Cells of these patients accumulate cat-
alytically inactive sulfatases that retain the cysteine residue,
which normally is oxidized by FGE to FGly (2). So far, no
mutations in the pFGE-encoding SUMF2 gene have been found
in multiple sulfatase deficiency patients.
Under conditions appropriate for the FGly-generating activ-
ity of FGE toward peptidic substrates, pFGE was inactive. This
was true for the peptides derived from the 16 sulfatases known
or predicted from the human genome sequence. This indicates
that under in vitro conditions, pFGE lacks FGly-generating
activity. The increase of sulfatase activity upon coexpression of
pFGE with sulfatases had suggested that in vivo pFGE has
FGly-generating activity or is stimulating the activity of en-
dogenous FGE (13). We failed to observe an increase of sulfat-
ase activity upon transient or stable coexpression of pFGE. In
HT-1080 cells, the coexpression of pFGE decreased rather than
increased the activity of coexpressed sulfatases. In an attempt
to understand this inhibitory effect, we examined the interac-
tion of pFGE with sulfatases and FGE. We could demonstrate
the interaction of an ASA fragment and short ASA-derived
peptides with pFGE in a yeast two-hybrid approach and by
photocross-linking, respectively. In a yeast two-hybrid assay,
we could also observe an interaction between pFGE and FGE.
This, however, could not be confirmed in approaches monitor-
ing a direct physical interaction of pFGE and FGE. Taken
together, our results support the view that pFGE lacks FGly-
generating activity. In vivo the overexpression of pFGE inter-
feres with the FGly formation in sulfatases indicated by the
decrease of sulfatase activity without concomitant decrease in
sulfatase polypeptide. This effect may be due to binding of
sulfatases to pFGE, thereby sequestrating them from FGE.
However, the effects of pFGE on FGE are also conceivable
either in an indirect manner, e.g. by dislocating FGE from the
endoplasmic reticulum due to competition for a common reten-
tion mechanism, or directly by heterodimerization. The latter
possibility agrees with the crystal structure of pFGE and is
discussed by Dickmanns et al. (24).
This study underlines the similarities of the non-catalytic
properties of pFGE and FGE and provides evidence that both
contact newly synthesized sulfatases in the endoplasmic retic-
ulum. However, the biological role of pFGE remains to be
defined. Detailed analysis of the molecular interaction of pFGE
and FGE and nascent sulfatase polypeptides as well as ablation
of pFGE may help elucidating its function.
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